Prellis Biologics

Prellis Biologics is a Berkeley, California biotechnology company that discovers fully human antibody therapeutics by combining wet-lab human immunology with machine learning. Its EXIS (Externalized Immune System) platform uses LNO lymph node organoids — 3D tissue printed with holographic two-photon photolithography — to recreate human lymph node biology in vitro, raise true human antibody responses across genetically diverse donors, and feed the resulting sequence and characterization data into generative AI models that predict and optimize candidates in an iterative lab loop. The company sells antibody discovery collaborations and licensed therapeutic programs to pharmaceutical partners rather than software, and publishes no public developer program, API, SDK, or machine-readable specification.

Prellis Biologics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Antibody Discovery, and Drug Discovery.

Prellis Biologics’ developer surface includes engineering blog, support, and 6 more developer resources.

10.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyBiotechnologyLife SciencesAntibody DiscoveryDrug DiscoveryArtificial IntelligenceMachine LearningBioprintingTherapeuticsResearch

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 10.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 1.1 / 17
Commercial Clarity 1.8 / 17
Operational Transparency 0.6 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/prellis-biologics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Prellis Biologics Domain Security

TLSv1.3 · HSTS · DNSSEC · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Build 1

SDKs, sample code, and the tooling you integrate with

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 3

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: prellis-biologics
name: Prellis Biologics
description: Prellis Biologics is a Berkeley, California biotechnology company that discovers fully human antibody therapeutics
  by combining wet-lab human immunology with machine learning. Its EXIS (Externalized Immune System) platform uses LNO lymph
  node organoids — 3D tissue printed with holographic two-photon photolithography — to recreate human lymph node biology in
  vitro, raise true human antibody responses across genetically diverse donors, and feed the resulting sequence and characterization
  data into generative AI models that predict and optimize candidates in an iterative lab loop. The company sells antibody
  discovery collaborations and licensed therapeutic programs to pharmaceutical partners rather than software, and publishes
  no public developer program, API, SDK, or machine-readable specification.
url: https://raw.githubusercontent.com/api-evangelist/prellis-biologics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-secondary-market: https://forgeglobal.com/prellis-biologics_stock/
x-tier: stub
x-tier-reason: harvest
image: https://cdn.sanity.io/images/km3brrze/production/7c3deebab6b574ce1b0943968cacc7c22cf94f20-1200x630.jpg
specificationVersion: '0.20'
created: '2026-08-05'
modified: '2026-08-05'
tags:
- Company
- Biotechnology
- Life Sciences
- Antibody Discovery
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Bioprinting
- Therapeutics
- Research
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/prellis-biologics-domain-security.yml
- type: Website
  url: https://prellisbio.com/
- type: About
  url: https://prellisbio.com/about
- type: Blog
  url: https://prellisbio.com/news-and-media
- type: PrivacyPolicy
  url: https://prellisbio.com/privacy-policy
- type: Support
  url: https://prellisbio.com/contacts
- type: GitHubOrganization
  url: https://github.com/PrellisBiologics
- type: LLMsTxt
  url: llms/prellis-biologics-llms.txt
x-enrichment:
  date: '2026-08-05'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Prellis Biologics sells antibody discovery collaborations and licensed therapeutic programs to pharma partners rather
    than software — its entire site is fourteen marketing pages with no developer, docs, platform or login section, and api./docs./developer./app.prellisbio.com
    do not resolve at all.
  evidence:
  - url: https://prellisbio.com/sitemap.xml
    status: 200
  - url: https://prellisbio.com/openapi.json
    status: 404
  - url: https://prellisbio.com/.well-known/agent-card.json
    status: 404
  - url: https://prellisbio.com/llms.txt
    status: 404
  - url: https://prellisbio.com/graphql
    status: 404
  checked: '2026-08-05'